VERBINDUNGEN, DIE WERTE SCHAFFEN.
HOMEHR CONSULTINGINDUSTRIES & POSITIONSREFERENCESTEAMHR DEVELOPMENTCAREER COACHINGTEAMTEAMJOBSCONTACT
ENDE

November 2023

We present you our LinkedIn posts in November!



We were part of pharmaKON 2023!

Eblinger & Partner was a proud part of the industry meeting at imh Gesundheitswesen Pharma, which this year was dedicated to the specialist areas of "Reimbursement" and "Market Access & Digitization in the Laboratory".

Charlotte Eblinger-Mitterlechner was the speaker and gave the keynote speech "War for Talents: Attracting & retaining YoungSTARS in the pharmaceutical sector" on the following topics:
 
- Current situation: demographics, skilled labor pool & expectations from and to the industry
- Generation what? Recruiting in the generation mix
- Social media, sustainability, work-life balance: What topics can companies use to attract young talent?
- What do new talents need in a company?

We discussed the future and challenges of the pharmaceutical industry in depth with almost 120 experts, managers and visionaries from the healthcare sector.




The Eblinger & Partner Office hosted an open training session on the topics of Diversity & Inclusion and Unconscious Bias.

Led by Charlotte Eblinger-Mitterlechner and Sandra Teisinger-Tüllenburg, the participants gained an in-depth insight into the important topic of diversity in the workplace and received practical solutions for integrating diversity and overcoming unconscious bias in the professional environment.

We would like to thank the ten committed participants, who came from different industries and thus contributed to an enriching discussion. The interdisciplinary participation reflected the relevance of the topics of Diversity & Inclusion and Unconscious Bias for companies of all kinds.



Further LinkedIn-posts see here

CAREER COACHING
UP TO DATE
NEWS
From Boardroom to C-Suite: Redefining Leadership in Consumer Markets
NEWS
Central Europe Executive Search Market Outlook 2024
NEWS
The AESC Diversity Pledge
BEST OF LINKEDIN
January 2024All posts from 2023